Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-3091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-3091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 01)

Image (Image 01)
Chemical structure of diltiazem hydrochloride shown as a molecular diagram with labeled functional groups and atoms, including aromatic rings, sulfur, nitrogen, oxygen, and methyl groups, alongside the hydrochloride component.*
FDA Label Image

Image (Image 02)

Image (Image 02)
Data table showing adverse reactions from placebo-controlled trials comparing diltiazem hydrochloride extended-release capsules (n=607) to placebo (n=301) in patients with angina and hypertension. It lists reaction types like headache, dizziness, bradycardia, AV block first degree, edema, and asthenia with corresponding incidence percentages for each group.*
FDA Label Image

Label (Lbl713353091)

Label (Lbl713353091)
Label for diltiazem hydrochloride extended-release capsules, USP 240 mg, by Bryant Ranch Prepack. The label shows product NDC 71335-3091-1, containing 30 capsules. It includes storage instructions, manufacturer Novast Laboratories Ltd, and caution to keep out of reach of children. Two QR codes are also present for package insert and dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.